<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font18">and </span>
   <span class="font13">vaccine </span>
   <span class="font13">The </span>
   <span class="font13">for </span>
   <span class="font12">with </span>
   <span class="font11">which </span>
   <span class="font11">al., </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">COVID- </span>
   <span class="font11">protein </span>
   <span class="font11">are </span>
   <span class="font11">has </span>
   <span class="font11">viral </span>
   <span class="font11">(Anon, </span>
   <span class="font11">Vaccine </span>
   <span class="font10">have </span>
   <span class="font10">immune </span>
   <span class="font10">that </span>
   <span class="font10">trials </span>
   <span class="font10">Phase </span>
   <span class="font10">clinical </span>
   <span class="font10">virus </span>
   <span class="font10">{background </span>
   <span class="font10">[Online] </span>
   <span class="font10">antibodies </span>
   <span class="font10">can </span>
   <span class="font10">from </span>
   <span class="font10">was </span>
   <span class="font10">against </span>
   <span class="font10">cell </span>
   <span class="font10">response </span>
   <span class="font10">Anon, </span>
   <span class="font10">DNA </span>
   <span class="font10">been </span>
   <span class="font10">[Cited: </span>
   <span class="font10">coronavirus </span>
   <span class="font10">June </span>
   <span class="font10">into </span>
   <span class="font10">mRNA </span>
   <span class="font10">margin </span>
   <span class="font10">may </span>
   <span class="font10">phase </span>
   <span class="font10">spike </span>
   <span class="font10">will </span>
   <span class="font10">Pre-Clinical </span>
   <span class="font10">This </span>
   <span class="font10">based </span>
   <span class="font10">development </span>
   <span class="font10">{border-style </span>
   <span class="font10">host </span>
   <span class="font10">human </span>
   <span class="font10">vaccines </span>
   <span class="font10">various </span>
   <span class="font10">neutralizing </span>
   <span class="font10">px;} </span>
   <span class="font10">recombinant </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">antibody </span>
   <span class="font10">its </span>
   <span class="font10">proteins </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Institute </span>
   <span class="font10">convalescent </span>
   <span class="font10">not </span>
   <span class="font10">this </span>
   <span class="font10">University </span>
   <span class="font10">NCT </span>
   <span class="font10">Virus; </span>
   <span class="font10">cells </span>
   <span class="font10">novel </span>
   <span class="font10">patients </span>
   <span class="font10">safety </span>
   <span class="font10">were </span>
   <span class="font10">administration </span>
   <span class="font10">after </span>
   <span class="font10">any </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">subunit </span>
   <span class="font10">these </span>
   <span class="font10">using </span>
   <span class="font10">However, </span>
   <span class="font10">Respiratory </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">all </span>
   <span class="font10">candidates </span>
   <span class="font10">developed </span>
   <span class="font10">dose </span>
   <span class="font10">genome </span>
   <span class="font10">specific </span>
   <span class="font10">used </span>
   <span class="font10">vaccines, </span>
   <span class="font10">vector </span>
   <span class="font10">Health </span>
   <span class="font10">Protein </span>
   <span class="font10">Vaccines </span>
   <span class="font10">also </span>
   <span class="font10">animal </span>
   <span class="font10">antigen </span>
   <span class="font10">immunity </span>
   <span class="font10">inactivated </span>
   <span class="font10">induce </span>
   <span class="font10">like </span>
   <span class="font10">receptor </span>
   <span class="font10">response. </span>
   <span class="font10">sequence </span>
   <span class="font10">therapy </span>
   <span class="font10">two </span>
   <span class="font10">upon </span>
   <span class="font10">use </span>
   <span class="font10">Acute </span>
   <span class="font10">Syndrome </span>
   <span class="font10">These </span>
   <span class="font10">along </span>
   <span class="font10">between </span>
   <span class="font10">candidate </span>
   <span class="font10">due </span>
   <span class="font10">etc. </span>
   <span class="font10">high </span>
   <span class="font10">immunogenic </span>
   <span class="font10">observed </span>
   <span class="font10">one </span>
   <span class="font10">other </span>
   <span class="font10">responses </span>
   <span class="font10">technology </span>
   <span class="font10">ChAdOx </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Disease </span>
   <span class="font10">RNA </span>
   <span class="font10">Table </span>
   <span class="font10">adverse </span>
   <span class="font10">binding </span>
   <span class="font10">both </span>
   <span class="font10">days </span>
   <span class="font10">different </span>
   <span class="font10">effective </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">infected </span>
   <span class="font10">infection </span>
   <span class="font10">infectious </span>
   <span class="font10">pandemic </span>
   <span class="font10">participants </span>
   <span class="font10">potential </span>
   <span class="font10">px; </span>
   <span class="font10">system </span>
   <span class="font10">treatment </span>
   <span class="font10">vaccines. </span>
   <span class="font10">while </span>
   <span class="font10">{font-family </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">Biotech </span>
   <span class="font10">Human </span>
   <span class="font10">Immunogenicity </span>
   <span class="font10">July </span>
   <span class="font10">May </span>
   <span class="font10">RBD </span>
   <span class="font10">Severe </span>
   <span class="font10">World </span>
   <span class="font10">adjuvant </span>
   <span class="font10">antigenic </span>
   <span class="font10">data </span>
   <span class="font10">developing </span>
   <span class="font10">development. </span>
   <span class="font10">disease </span>
   <span class="font10">entry </span>
   <span class="font10">font-size </span>
   <span class="font10">gene </span>
   <span class="font10">highly </span>
   <span class="font10">increase </span>
   <span class="font10">levels </span>
   <span class="font10">live </span>
   <span class="font10">monoclonal </span>
   <span class="font10">nAb </span>
   <span class="font10">plasma </span>
   <span class="font10">rapid </span>
   <span class="font10">responsible </span>
   <span class="font10">safe </span>
   <span class="font10">study </span>
   <span class="font10">target </span>
   <span class="font10">their </span>
   <span class="font10">therapeutic </span>
   <span class="font10">three </span>
   <span class="font10">titers </span>
   <span class="font10">vaccine/ </span>
   <span class="font10">â€¢It </span>
   <span class="font10">Against </span>
   <span class="font10">April </span>
   <span class="font10">Bharat </span>
   <span class="font10">Biological </span>
   <span class="font10">Clinical </span>
   <span class="font10">Domain </span>
   <span class="font10">I/II </span>
   <span class="font10">Live </span>
   <span class="font10">March </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">With </span>
   <span class="font10">amino </span>
   <span class="font10">antigens </span>
   <span class="font10">attenuated </span>
   <span class="font10">being </span>
   <span class="font10">but </span>
   <span class="font10">cells. </span>
   <span class="font10">develop </span>
   <span class="font10">double-blind, </span>
   <span class="font10">double; </span>
   <span class="font10">encoding </span>
   <span class="font10">evaluate </span>
   <span class="font10">further </span>
   <span class="font10">genes </span>
   <span class="font10">group </span>
   <span class="font10">higher </span>
   <span class="font10">large </span>
   <span class="font10">per </span>
   <span class="font10">population </span>
   <span class="font10">positive </span>
   <span class="font10">process </span>
   <span class="font10">requires </span>
   <span class="font10">research </span>
   <span class="font10">respiratory </span>
   <span class="font10">revealed </span>
   <span class="font10">some </span>
   <span class="font10">studies </span>
   <span class="font10">trials. </span>
   <span class="font10">uses </span>
   <span class="font10">within </span>
   <span class="font10">(University </span>
   <span class="font10">Attenuated </span>
   <span class="font10">Candidate </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Medical </span>
   <span class="font10">Molecular </span>
   <span class="font10">New </span>
   <span class="font10">Novel </span>
   <span class="font10">Plasma </span>
   <span class="font10">SARS </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Study </span>
   <span class="font10">Viral </span>
   <span class="font10">adenovirus </span>
   <span class="font10">administered </span>
   <span class="font10">antibodies. </span>
   <span class="font10">antiviral </span>
   <span class="font10">available </span>
   <span class="font10">bind </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">channels </span>
   <span class="font10">considered </span>
   <span class="font10">cytokine </span>
   <span class="font10">day </span>
   <span class="font10">diseases </span>
   <span class="font10">domain </span>
   <span class="font10">efficacy </span>
   <span class="font10">expression </span>
   <span class="font10">found </span>
   <span class="font10">functional </span>
   <span class="font10">hACE </span>
   <span class="font10">healthy </span>
   <span class="font10">humoral </span>
   <span class="font10">influenza </span>
   <span class="font10">least </span>
   <span class="font10">mice </span>
   <span class="font10">model </span>
   <span class="font10">models </span>
   <span class="font10">most </span>
   <span class="font10">must </span>
   <span class="font10">mutations </span>
   <span class="font10">particles </span>
   <span class="font10">placebo </span>
   <span class="font10">produce </span>
   <span class="font10">production </span>
   <span class="font10">protein, </span>
   <span class="font10">randomized, </span>
   <span class="font10">received </span>
   <span class="font10">replication </span>
   <span class="font10">reported </span>
   <span class="font10">second </span>
   <span class="font10">seroconversion </span>
   <span class="font10">single </span>
   <span class="font10">solid; </span>
   <span class="font10">status </span>
   <span class="font10">structural </span>
   <span class="font10">surface </span>
   <span class="font10">symptoms </span>
   <span class="font10">trial </span>
   <span class="font10">vaccination </span>
   <span class="font10">vaccine. </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Ou </span>
   <span class="font10">(Yoshimoto, </span>
   <span class="font10">Announces </span>
   <span class="font10">Antibody </span>
   <span class="font10">August </span>
   <span class="font10">Binding </span>
   <span class="font10">Center </span>
   <span class="font10">Clamp </span>
   <span class="font10">Covid- </span>
   <span class="font10">Delhi, </span>
   <span class="font10">Hong </span>
   <span class="font10">INO- </span>
   <span class="font10">Inc., </span>
   <span class="font10">Indian </span>
   <span class="font10">Kong </span>
   <span class="font10">Patients </span>
   <span class="font10">Receptor </span>
   <span class="font10">Research </span>
   <span class="font10">S-Protein </span>
   <span class="font10">SARS-CoV-: </span>
   <span class="font10">Safety </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">They </span>
   <span class="font10">Trials </span>
   <span class="font10">Virus </span>
   <span class="font10">Whereas, </span>
   <span class="font10">absence </span>
   <span class="font10">accelerate </span>
   <span class="font10">acid </span>
   <span class="font10">activate </span>
   <span class="font10">already </span>
   <span class="font10">analysis </span>
   <span class="font10">around </span>
   <span class="font10">before </span>
   <span class="font10">bold </span>
   <span class="font10">centre </span>
   <span class="font10">cleavage </span>
   <span class="font10">collaboration </span>
   <span class="font10">community </span>
   <span class="font10">conducted </span>
   <span class="font10">conformational </span>
   <span class="font10">contain </span>
   <span class="font10">controlled </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">courier; </span>
   <span class="font10">demonstrated </span>
   <span class="font10">does </span>
   <span class="font10">domains </span>
   <span class="font10">efforts </span>
   <span class="font10">either </span>
   <span class="font10">elicit </span>
   <span class="font10">em; </span>
   <span class="font10">enhance </span>
   <span class="font10">enhancement </span>
   <span class="font10">entered </span>
   <span class="font10">epitopes </span>
   <span class="font10">essential </span>
   <span class="font10">expressed </span>
   <span class="font10">expressing </span>
   <span class="font10">form </span>
   <span class="font10">genome. </span>
   <span class="font10">geometric </span>
   <span class="font10">including </span>
   <span class="font10">individuals </span>
   <span class="font10">inducing </span>
   <span class="font10">infection, </span>
   <span class="font10">inflammatory </span>
   <span class="font10">information </span>
   <span class="font10">international </span>
   <span class="font10">landscape </span>
   <span class="font10">led </span>
   <span class="font10">mAb </span>
   <span class="font10">mean </span>
   <span class="font10">measles </span>
   <span class="font10">medical </span>
   <span class="font10">nasal </span>
   <span class="font10">number </span>
   <span class="font10">only </span>
   <span class="font10">outbreak </span>
   <span class="font10">platform </span>
   <span class="font10">post-vaccination </span>
   <span class="font10">post-vaccination. </span>
   <span class="font10">pre-clinical </span>
   <span class="font10">pre-fusion </span>
   <span class="font10">preclinical </span>
   <span class="font10">preliminary </span>
   <span class="font10">prophylactic </span>
   <span class="font10">pt;} </span>
   <span class="font10">reactions </span>
   <span class="font10">researchers </span>
   <span class="font10">resource </span>
   <span class="font10">safety, </span>
   <span class="font10">self-limiting </span>
   <span class="font10">sera. </span>
   <span class="font10">serum </span>
   <span class="font10">severe </span>
   <span class="font10">shall </span>
   <span class="font10">significant </span>
   <span class="font10">similar </span>
   <span class="font10">structure </span>
   <span class="font10">suggest </span>
   <span class="font10">synthetic </span>
   <span class="font10">systemic </span>
   <span class="font10">than </span>
   <span class="font10">then </span>
   <span class="font10">therefore, </span>
   <span class="font10">through </span>
   <span class="font10">under </span>
   <span class="font10">undergo </span>
   <span class="font10">vaccine, </span>
   <span class="font10">via </span>
   <span class="font10">virus, </span>
   <span class="font10">volunteers </span>
   <span class="font10">well </span>
   <span class="font10">where </span>
   <span class="font10">who </span>
   <span class="font10">working </span>
  </p>
 </body>
</html>
